At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna shares.
More encouraging still, it points the way to a better way of preventing cancer’s recurrence. Current treatments sometimes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results